Ed C. Tidswell, PhD Merck & Co., Inc.

Dr. Tidswell is Executive Director within the Microbiology Quality and Sterility Assurance organization of Merck Inc. with ownership over sterility assurance and microbiology issues across all sterile and non-sterile products and manufacturing. His prior appointments include senior global R&D, and quality leadership roles across diverse drug, device and biologics portfolios for the likes of Baxter Healthcare, Eli Lilly and Evans Vaccines. Dr. Tidswell actively publishes and is a leading authority on pharmaceutical microbiology, risk, aseptic and sterile manufacturing. Currently a member of the PDA Journal’s Editorial Board, and continues to serve on the USP Expert Committee for Microbiology.